Services Agreement Addendum No. 1 between Phage Biotechnology Corporation and MPI Research, Inc. (November 2004)
This addendum is an agreement between Phage Biotechnology Corporation and MPI Research, Inc. for a single dose pharmacokinetic study of recombinant human growth factor (FGF-1) in rats. The study is scheduled to start on November 17, 2004, with a total price of $13,900, payable in installments based on project milestones. The addendum is governed by the terms of a prior master agreement between the parties and outlines payment terms and procedures for any price modifications during the study.
EXHIBIT 10.14(a)
[LETTERHEAD OF MPI RESEARCH]
SERVICES AGREEMENT ADDENDUM No. 1
Sponsor: Phage Biotechnology Corporation
Sponsor’s Representative: Jack Jacobs, Ph.D.
Date: November 19, 2004
Study Type: A Single Dose Pharmacokinetic Study of Recombinant Human Growth Factor (FGF-1) in Rats
Study Director: Mr. Robert Tawoda
Sponsor’s Study No:
MPI Research Study No.: 1118-001
MPI Research Proposal No.: 04-082217
Study Schedule:
| Estimated Start Date: | November 17, 2004 | |||
| Estimated Date of Terminal Necropsy: | To Be Determined | |||
| Estimated Audited Draft Report Date: | To Be Determined |
Study Price: $13,900 Original
Payment Schedule:
| Animal Acquisition | $8,300 | |||
| 30 Days After Initial Billing | $4,200 | |||
| At Mailing of Audited Draft Report | $1,400 |
THE WORK DESCRIBED IN THIS PROTOCOL WILL BE DONE UNDER THE TERMS AND CONDITIONS OF THE MASTER AGREEMENT BETWEEN MPI RESEARCH AND (Enter Sponsor Here) DATED (Enter Date Here) AND THIS ADDENDUM NO. IS INCORPORATED INTO AND MADE A PART OF SAID MASTER AGREEMENT. MODIFICATIONS TO THE STUDY PRICE, MUTUALLY AGREED UPON IN WRITING BY THE PARTIES, THAT OCCUR DURING THE COURSE OF THE ABOVE DEFINED PAYMENT SCHEDULE WILL BE REFLECTED ON THE NEXT SCHEDULED INVOICE, UNLESS OTHERWISE NOTED.
| /s/ JACK JACOBS | /s/ ANDREJS DUMPIS | |||
| On behalf of (Enter Sponsor Here) | On behalf of MPI Research, Inc. | |||
| Date: 11/21/04 | Date: 11/17/04 | |||
